期刊
HUMAN REPRODUCTION
卷 25, 期 11, 页码 2678-2684出版社
OXFORD UNIV PRESS
DOI: 10.1093/humrep/deq247
关键词
mild ovarian stimulation; IVF; GnRH antagonist; infertility; FSH
资金
- Andromed
- Ardana
- Ferring
- Genovum
- Glycotope
- Merck Serono
- Organon
- Pantharei Bioscience
- Philips
- PregLem
- Schering
- Schering Plough
- Serono
- Wyeth
- IBSA
- Organon Schering Plough
- Ipsen
Ovarian stimulation to achieve multiple follicle development has been an integral part of IVF treatment. In the context of improved laboratory performance, the need for a large number of oocytes as an integral part of a successful IVF programme may be questioned. The aim of the current debate is to summarize the studies performed during the last decade to develop the concept of mild stimulation aiming to obtain fewer than eight oocytes. Here we examine the balance between IVF success and patient discomfort, and complications and cost, and how these might improve by simpler ovarian stimulation protocols aimed at retrieving fewer oocytes. We intend to analyse why progress has been rather slow and why there is much resistance to mild stimulation. Finally, presumed useful directions for future research will be discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据